ReviewFrontiers in pharmacology2022

Programmed Cell Death Protein 1/Programmed Cell Death Protein Ligand 1 Immunosuppressants in Advanced Non-Small Cell Lung Cancer Research Progress in Treatment.

Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.